FDA Panel Backs Merck COVID Pill For High-Risk Adults
A split U.S. Food and Drug Administration advisory committee on Tuesday voted in favor of emergency use authorization for an antiviral pill developed by Merck & Co. and Ridgeback Biotherapeutics to...To view the full article, register now.
Already a subscriber? Click here to view full article